1. Home
  2. VNRX vs BHM Comparison

VNRX vs BHM Comparison

Compare VNRX & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • BHM
  • Stock Information
  • Founded
  • VNRX N/A
  • BHM 2022
  • Country
  • VNRX United States
  • BHM United States
  • Employees
  • VNRX N/A
  • BHM N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BHM Real Estate Investment Trusts
  • Sector
  • VNRX Health Care
  • BHM Real Estate
  • Exchange
  • VNRX Nasdaq
  • BHM Nasdaq
  • Market Cap
  • VNRX 52.4M
  • BHM 52.0M
  • IPO Year
  • VNRX N/A
  • BHM N/A
  • Fundamental
  • Price
  • VNRX $0.67
  • BHM $13.27
  • Analyst Decision
  • VNRX Strong Buy
  • BHM Strong Buy
  • Analyst Count
  • VNRX 5
  • BHM 1
  • Target Price
  • VNRX $3.88
  • BHM $15.00
  • AVG Volume (30 Days)
  • VNRX 307.2K
  • BHM 2.5K
  • Earning Date
  • VNRX 08-13-2025
  • BHM 01-01-0001
  • Dividend Yield
  • VNRX N/A
  • BHM 3.76%
  • EPS Growth
  • VNRX N/A
  • BHM N/A
  • EPS
  • VNRX N/A
  • BHM N/A
  • Revenue
  • VNRX $1,308,361.00
  • BHM $67,757,000.00
  • Revenue This Year
  • VNRX $563.72
  • BHM N/A
  • Revenue Next Year
  • VNRX $160.43
  • BHM N/A
  • P/E Ratio
  • VNRX N/A
  • BHM N/A
  • Revenue Growth
  • VNRX 64.16
  • BHM 26.16
  • 52 Week Low
  • VNRX $0.40
  • BHM $9.30
  • 52 Week High
  • VNRX $0.94
  • BHM $19.01
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 48.82
  • BHM 62.45
  • Support Level
  • VNRX $0.62
  • BHM $12.88
  • Resistance Level
  • VNRX $0.76
  • BHM $13.17
  • Average True Range (ATR)
  • VNRX 0.08
  • BHM 0.25
  • MACD
  • VNRX -0.02
  • BHM -0.03
  • Stochastic Oscillator
  • VNRX 16.73
  • BHM 83.91

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties, including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. Its objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments scattered single-family homes and residential communities. The company generates the majority of its revenue from the Scattered single-family homes segment.

Share on Social Networks: